E6130

DRUG2 trials

Sponsors

EA Pharma Co., Ltd.

Conditions

Healthy ParticipantsJapanese Healthy Adult Male Participants

Phase 1

A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

CompletedNCT02902978

EA Pharma Co., Ltd.Japanese Healthy Adult Male Participants

Start: 2016-09-26End: 2017-08-17Updated: 2018-09-06

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Male Participants

WithdrawnNCT03390647

EA Pharma Co., Ltd.Healthy Participants

Start: 2017-12-21End: 2019-03-31Updated: 2018-07-31